NeuBase Therapeutics Inc. (NBSE)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 1 |
Ownership rank: | 686 |
% of all portfolios: | 0% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
0 |
$0 |
Sells |
0 |
$0 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
07 Sep 2023 |
SYMETRYX CORP |
10% |
01 Sep 2023 |
61,076 |
0.98 |
59,732 |
01 Apr 2022 |
MANN WILLIAM ROLAND |
Chief Operating Officer |
30 Mar 2022 |
6,200 |
1.92 |
11,904 |
21 Mar 2022 |
BRANNING TODD P. |
Chief Financial Officer |
18 Mar 2022 |
10,000 |
1.81 |
18,100 |
18 Mar 2022 |
BRANNING TODD P. |
Chief Financial Officer |
17 Mar 2022 |
10,000 |
1.74 |
17,400 |
18 Mar 2022 |
BRANNING TODD P. |
Chief Financial Officer |
16 Mar 2022 |
10,000 |
1.62 |
16,200 |
07 Mar 2022 |
RICHMAN ERIC I |
Director |
04 Mar 2022 |
1,000 |
1.62 |
1,620 |
07 Mar 2022 |
RICHMAN ERIC I |
Director |
03 Mar 2022 |
1,300 |
1.72 |
2,236 |
07 Mar 2022 |
RICHMAN ERIC I |
Director |
01 Mar 2022 |
1,580 |
1.58 |
2,496 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock